We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B Turnover 22.5%
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+7.04%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.37B
AUM Growth
+$62.8M
Cap. Flow
-$112M
Cap. Flow %
-2.09%
Top 10 Hldgs %
20.35%
Holding
855
New
121
Increased
189
Reduced
310
Closed
120
Avg Time Held
1 year
Top 10 Avg Time Held
0.6 years
Top 20 Avg Time Held
0.6 years

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$45.7M
2
IDXX icon
Idexx Laboratories
IDXX
+$34.3M
3
CAH icon
Cardinal Health
CAH
+$30.2M
4
AMAT icon
Applied Materials
AMAT
+$24.5M
5
ELV icon
Elevance Health
ELV
+$24.1M

Sector Composition

Rank Sector Weight
1 Healthcare 18.73%
2 Financials 15.53%
3 Industrials 13.23%
4 Consumer Discretionary 12.83%
5 Technology 10.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AEK.CL
226
DELISTED
Aegon NV
AEK.CL
$1.48M 0.03%
52,566
– –
2013 Q2
6 quarters
ROK icon
227
Rockwell Automation
ROK
$46.9B
$1.47M 0.03%
13,216
-257,908
-95% -$28.3M
2013 Q2
6 quarters
YUM icon
228
Yum! Brands
YUM
$41.2B
$1.46M 0.03%
27,773
-1,937
-7% -$101K
2013 Q2
6 quarters
VFC icon
229
VF Corp
VFC
$6.68B
$1.45M 0.03%
20,575
+127
+0.6% +$8.4K
2014 Q1
3 quarters
IBN icon
230
ICICI Bank
IBN
$106B
$1.45M 0.03%
137,583
-37,829
-22% -$386K
2014 Q1
3 quarters
QQQ icon
231
Invesco QQQ Trust
QQQ
$487B
$1.44M 0.03%
13,961
+192
+1% +$19.4K
2013 Q2
6 quarters
BLK icon
232
Blackrock
BLK
$174B
$1.44M 0.03%
4,028
-309
-7% -$106K
2013 Q2
6 quarters
LAZ icon
233
Lazard
LAZ
$3.52B
$1.44M 0.03%
28,693
-56,988
-67% -$2.83M
2013 Q2
6 quarters
LKQ icon
234
LKQ Corp
LKQ
$5.66B
$1.43M 0.03%
50,955
-25
-0% -$698
2013 Q2
6 quarters
VTI icon
235
Vanguard Morningstar Total Stock Market ETF
VTI
$697B
$1.42M 0.03%
13,406
+476
+4% +$49.3K
2014 Q1
3 quarters
LVS icon
236
Las Vegas Sands
LVS
$24.8B
$1.39M 0.03%
23,810
-1,288
-5% -$77.6K
2013 Q2
6 quarters
MNST icon
237
Monster Beverage
MNST
$88.8B
$1.38M 0.03%
+152,700
New +$1.32M
2014 Q4
0 quarters
CL icon
238
Colgate-Palmolive
CL
$73.9B
$1.38M 0.03%
19,875
-3,972
-17% -$268K
2013 Q2
6 quarters
PLL icon
239
DELISTED
PALL CORP
PLL
$1.36M 0.03%
13,419
-564
-4% -$52K
2013 Q2
6 quarters
BKD icon
240
Brookdale Senior Living
BKD
$2.41B
$1.35M 0.03%
36,860
+24,220
+192% +$821K
2014 Q3
1 quarter
MRK icon
241
Merck
MRK
$358B
$1.34M 0.03%
24,774
-965
-4% -$53.8K
2013 Q2
6 quarters
SYK icon
242
Stryker
SYK
$112B
$1.31M 0.02%
13,931
+3,784
+37% +$336K
2013 Q2
6 quarters
LLY icon
243
Eli Lilly
LLY
$1.12T
$1.29M 0.02%
18,744
+790
+4% +$53.3K
2013 Q2
6 quarters
PTR
244
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$1.29M 0.02%
11,645
-920
-7% -$107K
2013 Q2
6 quarters
USB icon
245
US Bancorp
USB
$89.4B
$1.27M 0.02%
28,178
-3,711
-12% -$160K
2013 Q2
6 quarters
EMR icon
246
Emerson Electric
EMR
$90.4B
$1.24M 0.02%
20,140
+120
+0.6% +$7.52K
2013 Q2
6 quarters
DEO icon
247
Diageo
DEO
$52.3B
$1.24M 0.02%
10,883
-752
-6% -$87.4K
2013 Q2
6 quarters
TM icon
248
Toyota
TM
$226B
$1.22M 0.02%
+9,700
New +$1.17M
2014 Q4
0 quarters
CERN
249
DELISTED
Cerner Corp
CERN
$1.2M 0.02%
18,547
-2,035
-10% -$127K
2014 Q1
3 quarters
FEIC
250
DELISTED
FEI COMPANY
FEIC
$1.19M 0.02%
13,175
-1,295
-9% -$108K
2014 Q2
2 quarters

Similar funds

Geneva Advisors's Q4 2014 Portfolio in Review

As of Q4 2014, Geneva Advisors held 855 positions worth $5.37B, up 1.2% from $5.31B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Geneva Advisors's Q4 2014 filing shows 121 new, 189 increased, 310 reduced and 120 closed positions. Its largest new stake was Idexx Laboratories: 488,650 shares worth $36.2M. The largest sale was LyondellBasell Industries, an estimated $73.1M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

  • Geneva Advisors's largest Q4 2014 buy was Idexx Laboratories: 488,650 shares worth $36.2M.
  • Geneva Advisors added most to Alibaba in Q4 2014, an estimated $45.7M increase.
  • Geneva Advisors's biggest Q4 2014 reduction was LyondellBasell Industries, cutting an estimated $73.1M.
  • Geneva Advisors fully exited Community Health Systems in Q4 2014, selling an estimated $13M.
  • Geneva Advisors's ten largest holdings make up 20% of its $5.37B portfolio in Q4 2014.
  • Geneva Advisors opened 121 new positions and closed 120 in Q4 2014.
  • Geneva Advisors's portfolio value rose 1.2% quarter-over-quarter to $5.37B.

Based on Geneva Advisors's 13F filing for Q4 2014, filed 2 Feb 2015.